Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure

G. Michael Felker; Wendy A. Gattis; Jeffrey D. Leimberger; Kirkwood F. Adams; Michael S. Cuffe; Mihai Gheorghiade; Christopher M. O'Connor

doi:10.1016/S0002-9149(03)00740-9

Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure

G. Michael Felker^*, Wendy A. Gattis, Jeffrey D. Leimberger, Kirkwood F. Adams, Michael S. Cuffe, Mihai Gheorghiade, Christopher M. O'Connor

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Article › peer-review

193 Scopus citations

Abstract

We investigated the prevalence of anemia and its relation to clinical events in patients with decompensated heart failure enrolled in the OPTIME-CHF study. Our data demonstrate that anemia is common in patients hospitalized with decompensated heart failure and is associated with a greater number of co-morbid conditions. Lower baseline hemoglobin is associated with risk of short-term adverse clinical outcomes in this population, even after controlling for other baseline differences.

Original language	English (US)
Pages (from-to)	625-628
Number of pages	4
Journal	American Journal of Cardiology
Volume	92
Issue number	5
DOIs	https://doi.org/10.1016/S0002-9149(03)00740-9
State	Published - Aug 22 2003

Funding

The OPTIME-CHF study was funded by Sanofi-Synthelabo, New York, New York, but this analysis was funded independently by Duke Clinical Research Institute.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/S0002-9149(03)00740-9

Cite this

@article{7604c0ea7b07451ea83c85f1e59e7bfe,

title = "Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure",

abstract = "We investigated the prevalence of anemia and its relation to clinical events in patients with decompensated heart failure enrolled in the OPTIME-CHF study. Our data demonstrate that anemia is common in patients hospitalized with decompensated heart failure and is associated with a greater number of co-morbid conditions. Lower baseline hemoglobin is associated with risk of short-term adverse clinical outcomes in this population, even after controlling for other baseline differences.",

author = "Felker, {G. Michael} and Gattis, {Wendy A.} and Leimberger, {Jeffrey D.} and Adams, {Kirkwood F.} and Cuffe, {Michael S.} and Mihai Gheorghiade and O'Connor, {Christopher M.}",

note = "Funding Information: The OPTIME-CHF study was funded by Sanofi-Synthelabo, New York, New York, but this analysis was funded independently by Duke Clinical Research Institute. ",

year = "2003",

month = aug,

day = "22",

doi = "10.1016/S0002-9149(03)00740-9",

language = "English (US)",

volume = "92",

pages = "625--628",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure

AU - Felker, G. Michael

AU - Gattis, Wendy A.

AU - Leimberger, Jeffrey D.

AU - Adams, Kirkwood F.

AU - Cuffe, Michael S.

AU - Gheorghiade, Mihai

AU - O'Connor, Christopher M.

N1 - Funding Information: The OPTIME-CHF study was funded by Sanofi-Synthelabo, New York, New York, but this analysis was funded independently by Duke Clinical Research Institute.

PY - 2003/8/22

Y1 - 2003/8/22

N2 - We investigated the prevalence of anemia and its relation to clinical events in patients with decompensated heart failure enrolled in the OPTIME-CHF study. Our data demonstrate that anemia is common in patients hospitalized with decompensated heart failure and is associated with a greater number of co-morbid conditions. Lower baseline hemoglobin is associated with risk of short-term adverse clinical outcomes in this population, even after controlling for other baseline differences.

AB - We investigated the prevalence of anemia and its relation to clinical events in patients with decompensated heart failure enrolled in the OPTIME-CHF study. Our data demonstrate that anemia is common in patients hospitalized with decompensated heart failure and is associated with a greater number of co-morbid conditions. Lower baseline hemoglobin is associated with risk of short-term adverse clinical outcomes in this population, even after controlling for other baseline differences.

UR - http://www.scopus.com/inward/record.url?scp=0043011312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043011312&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(03)00740-9

DO - 10.1016/S0002-9149(03)00740-9

M3 - Article

C2 - 12943893

AN - SCOPUS:0043011312

SN - 0002-9149

VL - 92

SP - 625

EP - 628

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 5

ER -

Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure

Abstract

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this